Home » Topics » BioWorld Science

BioWorld Science
RSS

CHIN-117 reduces inflammation in murine model of colitis

May 27, 2022

PAI-1-TFT therapy shows promise for treating pleural empyema

May 26, 2022

Ellipses Pharma licenses rights to SunRock's bifunctional HER3:TRAIL fusion protein

May 26, 2022

HotSpot and Excelra partner to support HotSpot's allosteric inhibitor candidate pipeline

May 26, 2022

CureVac and myNEO enter research and option agreement toward development of mRNA cancer vaccines

May 26, 2022

U.S. researchers present new NR1D2 agonists

May 26, 2022

New EGFR inhibitors identified at Lengo Therapeutics

May 26, 2022

Rhizen Pharmaceuticals divulges new PARP inhibitors

May 26, 2022

Evusheld retains neutralization activity against SARS-CoV-2 Omicron BA.4 and BA.5 variants

May 26, 2022

Bivalent Epstein-Barr nanoparticle vaccine protects against infection in mice

May 26, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...